Medical News

RSS

Highlights of world's largest ophthalmic education conference

Results of clinical research on new presbyopia treatments now available in Europe-and possibly available soon in the United States-were reported in today's Scientific Program of the 2010 Joint Meeting of the American Academy of Ophthalmology (AAO) and Middle East-Africa Council of Ophthalmology (MEACO). The AAO-MEACO meeting is the world's largest, most comprehensive ophthalmic education conference and is in session October 16 through 19 at McCormick Place, Chicago.

20 Oct 2010

PBS-Bio announces three new contracts to develop cancer therapy

In an industry that faces increasing challenges in delivering new drugs to patients, Predictive Biomarker Sciences (PBS-Bio) today announced three new contracts aimed at bringing new medicines to the marketplace.

20 Oct 2010

China Cord Blood files amendment to Annual Report on Form 20-F/A

China Cord Blood Corporation the first and largest cord blood bank operator in China, today announced that the Company has filed an amendment to its Annual Report on Form 20-F/A, which included audited financial statements for the fiscal year ended March 31, 2010 with the U.S. Securities and Exchange Commission.

20 Oct 2010

More education and attention needed on inflammatory breast cancer

Inflammatory breast cancer (IBC), an aggressive and rare malignancy, is often initially misdiagnosed as an infection or rash. However, getting the correct diagnosis quickly is critical for patients because the disease spreads beyond the breast in a matter of just days or weeks.

20 Oct 2010

$More studies needed on bisphosphonates therapy and fracture risk$

More studies needed on bisphosphonates therapy and fracture risk

On October 13, the Food and Drug Administration published a warning to doctors and patients about an increased risk of thigh fractures with a widely used group of bone-strengthening drugs called bisphosphonates. This warning was much awaited in the light of a report published in the American Journal of Bone and Mineral Research in September titled "Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research."

20 Oct 2010

New report focuses on inflammatory breast cancer

A rare and deadly form of breast cancer that often goes unrecognized by clinicians and patients alike is the focus of a new report from leading researchers. Inflammatory breast cancer (IBC) has made headlines as an unrecognized and misunderstood form of breast cancer. It has a younger age of onset, progresses rapidly, and has lower overall survival compared to other breast cancers.

20 Oct 2010

Minnesota health care organizations share patient EHRs through network of interoperable systems

Eight of the largest health care organizations in Minnesota have successfully launched software that enables electronic sharing of patient records across the group - and with other network members nationwide. The network of interoperable systems allows for an estimated 75 percent of Minnesotans (3.6 million patients) to show up at any one of the organizations' hospitals or clinics and have records from previous visits immediately available to doctors.

20 Oct 2010

Study finds massive blood transfusion associated with severe complications

A study presented at this year's American Society of Anesthesiologists Annual Meeting indicates that massive blood transfusion is associated with a significant increase in perioperative risk for mortality, cardiopulmonary complications, and wound-related and infectious complications in the long term.

20 Oct 2010

National Pap Test Campaign for cervical cancer diagnosis

The Federation of Medical Women of Canada (FMWC) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) are ready to launch this year's National Pap Test Campaign, to take place during National Cervical Cancer Awareness Week. From October 24th to 30th, over 100 health-care professionals across Canada are taking a stand against cervical cancer by hosting public Pap test clinics in their community.

20 Oct 2010

First in vivo screening system for complete human nuclear hormone receptor family

The InDanio screening system can be used, for example, to functionally characterize 'orphan' receptors - those for which their natural ligands or specific function are unknown - and thus qualify them as potential targets for drug discovery. The system can also be used to screen compound libraries in order to identify and refine potential new drugs that target NR proteins.

20 Oct 2010

New sandwich wheat bread is an excellent source of antioxidants

In its continuing commitment as a leader in the bread industry, Texas-based Mrs Baird's becomes the first major baking company in its region to fortify its line of sandwich wheat breads, now providing an excellent source of antioxidant vitamins A and E.

20 Oct 2010

Vivakor enters global licensing agreement with MIT Holding for Vivathermic Vials

Vivakor, Inc. announces today that it has entered into an exclusive licensing agreement with MIT Holding Inc. to manage all distribution of its Vivathermic Vials worldwide. Chairman Matt Nicosia adds the following statement to the news: "This is a great step forward in the distribution of Vivakor technology.

20 Oct 2010

Researchers to develop tailor-made pain management strategies for chronic pain

Research presented at this year's American Society of Anesthesiologists Annual Meeting offers new data in the quest to develop tailor-made pain management strategies based upon a patient's genetic predisposition and other important factors.

20 Oct 2010

MU researchers examine Aspergillus fumigatus to find cure for fungus, parasite

If finding the cure for a fungus and parasite that affects millions of people were the subject of a detective show, University of Missouri Chemistry Professor John Tanner would be the forensic expert in the lab, using high-tech equipment to make a model that could eventually solve the crime.

20 Oct 2010

Neuralstem updates Phase I human clinical trial of spinal cord stem cells for ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

20 Oct 2010

Loyola University Chicago MNSON supports recommendations to advance nursing profession

Loyola University Chicago Marcella Niehoff School of Nursing (MNSON) supports the recommendations recently issued by The Robert Wood Johnson Foundation and the Institute of Medicine to advance the nursing profession in the United States.

20 Oct 2010

Pharsight launches Phoenix Pharmacometric Productivity Challenge

Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.

20 Oct 2010

FDA provides update on three-part study of LASIK procedure

The U.S. Food and Drug Administration today provided an update on a three-part study of LASIK (Laser-Assisted in situ Keratomileusis), a vision improvement procedure.

20 Oct 2010

Microsulis tissue ablation systems presented at London meeting

Dr Peter Clegg, from the University of Bath microwave science team, who invented and developed the Microsulis microwave tissue ablation systems for destroying tumours, presented an overview of the success of this technology at the recent 'Changing Worlds Showcase Impact of University Research' meeting held in London.

20 Oct 2010

Carbon dioxide plays a role in gene regulation: Research

UCD Conway researchers have found that carbon dioxide (CO2) is not only involved in climate change and a waste product of respiration in cells but also plays an active role in regulating the genes involved in inflammation and innate immunity. Their research findings were highlighted recently in the The Journal of Immunology.

20 Oct 2010